Skip to main content
. 2017 Sep 28;8(54):92431–92441. doi: 10.18632/oncotarget.21369

Table 4. Total risk score and the predicted 2–5-year risk of hepatocellular carcinoma in the development group (n = 883).

Risk scores Year 2 Year 3 Year 4 Year 5
0 0.5% 0.8% 1.8% 2.4%
1 0.8% 1.2% 2.5% 3.5%
2 1.1% 1.7% 3.6% 4.9%
3 1.5% 2.4% 5.1% 6.9%
4 2.2% 3.4% 7.1% 9.7%
5 3.1% 4.7% 10.0% 13.4%
6 4.3% 6.7% 13.9% 18.6%
7 6.1% 9.3% 19.1% 25.3%
8 8.6% 13.0% 26.1% 34.0%
9 12.0% 18.0% 34.9% 44.6%
10 16.6% 24.6% 45.7% 56.9%
11 22.8% 33.1% 58.1% 69.8%
12 30.8% 43.5% 70.9% 81.8%
13 40.8% 55.6% 82.8% 91.1%
14 52.5% 68.5% 91.8% 96.8%
15 65.3% 80.7% 97.1% 99.3%